Project Grant R01DK142686
- Federal Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $580,568 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 1, 2025, through June 30, 2029, funds research investigating CD45-mediated regulation of neutrophil (polymorphonuclear leukocyte) function...
- Federal Grant Award Summary The University of Michigan received a $776,863 Project Grant awarded on September 15, 2025, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports multi-ancestry whole genome sequencing analyses of metabolic dysfunction-associated steatotic liver disease (MASLD) with functional follow-up studies through August 31, 2030. The research...
- Federal Grant Award Summary The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 12, 2025, through July 31, 2030. The award funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered, evidence-based diabetes self-management support (DSMS)...
- Federal Grant Award Summary The University of Michigan received a $611,447 R01 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, with a completion date of June 30, 2030. The award supports basic biomedical research to define a novel signaling axis regulating gastric epithelial cell homeostasis and response to injury, specifically...
- Federal Project Grant Award Summary The University of Michigan received a $377,648 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 18, 2025 through December 31, 2027. This award funds postdoctoral training and research aimed at elucidating the mechanisms of Notch signaling in intestinal stem cells (ISCs) and their interaction with...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $681,562 Project Grant on July 21, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports a research initiative focused on promoting metabolic maturity of islet organoids derived from human pluripotent stem cells (HPSC) for Type 1 Diabetes treatment. The research addresses a...
- Federal Project Grant Award Summary The University of Michigan received a $196,418 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through May 31, 2030. This research grant supports a comprehensive investigation into novel diagnostic and therapeutic approaches for acute kidney injury (AKI) in patients with cirrhosis. The...
- Federal Grant Award Summary The University of Michigan received a $878,614 Project Grant award effective March 1, 2026, through December 31, 2030, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports implementation of precision medicine for glomerular diseases within the Nephrotic Syndrome Study Network (NEPTUNE), leveraging a mature research...
- Federal Grant Award Summary The University of Michigan's Regents received a $779,978 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 6, 2025, with completion targeted for July 31, 2030. This research initiative will deliver a Sequential Multiple Assignment Randomized Trial (SMART) study designed to identify optimal adaptive...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a Project Grant of $728,801 on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Testing a Novel Weight Navigation Program to Overcome Multilevel Barriers to Obesity Treatment in Primary Care Settings," extends through June 30, 2030, and...
The University of Michigan received a $777,956 Project Grant award dated March 1, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project, extending through December 31, 2029, will develop and validate computer vision and machine learning models to improve the detection of dysplasia (pre-cancerous lesions) in patients with inflammatory bowel disease (IBD) during colonoscopy procedures and histologic evaluation. The research addresses a critical clinical need, as IBD-related dysplasia is difficult to detect using conventional colonoscopic visualization due to flat, irregular lesions obscured by inflammation, and existing enhancement techniques are resource-intensive without proven efficacy improvements. The deliverables include advanced computer vision models trained to match or exceed expert diagnostic capabilities in identifying dysplasia on both colonoscopic imagery and histologic samples. By adapting the research team's prior machine learning methodology developed for endoscopic disease activity assessments, the project will create tools to reduce pathologist diagnostic ambiguity and eliminate the need for expert second-opinion referrals for dysplasia grading. This research directly supports NIDDK's programmatic emphasis on improving prevention, diagnosis, and treatment of digestive diseases through fundamental and clinical investigation.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $778.0k | 2/16/26 |